在本次发行中，轻松健康集团引入广东横琴粤澳深度合作区澳琴合鸣投资合伙企业（有限合伙）（注：中金资本担任执行事务 合伙人）作为基石投资者，认购1亿元人民币。此前，轻松健康集团还已获得IDG资本、阳光保险集团、德同资本、道生资本、 腾讯等知名机构的投资。 成立于2014年的轻松健康集团作为一站式数字健康与保险服务平台，现已构建"数字综合健康服务"与"数字综合保险服务"两大 业务支柱，覆盖健康科普、数字营销、医学研究辅助、保险经纪及智能风控等多个环节。 AI技术成增长重要引擎。 据IPO早知道消息，轻松健康集团今起招股、至18日结束，并计划于2025年12月23日正式以"2661"为股票代码在港交所主板挂牌 上市。 轻松健康集团计划在本次IPO中发行26,540,000股股份。其中，香港公开发售2,654,000股股份，国际发售23,886,000股股份。按每 股22.68港元的发行价计算，轻松健康集团将通过本次IPO募集超6亿港元，IPO市值为46.81亿港元。 基于各个领域的技术，轻松健康集团显著提升了运营效率，降低了运营成本，并实现了营销策略的转型。具体来讲，银河AI营 销平台利用深度学习模型开展高度个性化的 ...

Core Viewpoint - QingSong Health Corporation has passed the listing hearing on the Hong Kong Stock Exchange, marking its official entry into the capital market as a leading health technology platform in China [2] Group 1: Business Overview - Since its establishment in 2014, QingSong Health Corporation has focused on innovation in digital health and smart insurance, supported by significant investments from top-tier institutions like IDG Capital and Tencent [3] - The company operates a dual-driven model with "digital comprehensive health" and "digital comprehensive insurance," creating significant synergies between the two business segments [3] Group 2: Digital Health Business Growth - The digital health segment is experiencing rapid expansion, with a focus on customized digital marketing solutions for pharmaceutical companies and charities, resulting in a substantial increase in health-related content production [4] - The company has organized over 1,000, 1,500, and 4,800 screening events from 2022 to 2025, significantly increasing user engagement and brand recognition [5] Group 3: Digital Insurance Business - The digital insurance segment has become a profit pillar, with a strong cash flow generation model based on fixed fees from service usage, enhancing financial resilience [6] - Insurance brokerage revenue reached 50.7 million yuan in the first half of 2025, with a growing number of policyholders and policies issued over the years [6] Group 4: User Base and Competitive Advantage - As of June 30, 2025, the company has nearly 170 million registered users, with a significant portion being young adults, providing opportunities for cross-selling and long-term value extraction [7] - The company has established a robust ecosystem that enhances brand influence and facilitates user acquisition through data-driven strategies [7][10] Group 5: Financial Performance - The company reported a revenue of 656.1 million yuan in the first half of 2025, an increase of 84.8% year-on-year, indicating successful strategic transformation towards technology and digital marketing [12] - Adjusted net profit for the first half of 2025 was 51.2 million yuan, reflecting a growth of 11.4% compared to the previous year [12] Group 6: Market Potential - The Chinese health service market is projected to grow from 622.61 billion yuan in 2020 to 814.94 billion yuan in 2024, with a compound annual growth rate of 7.0%, indicating significant expansion opportunities for the company [13]

Core Viewpoint - The company, Qingsong Health Group, has developed a proprietary AI technology stack, AIcare, which serves as the core support for its platform and is preparing for an IPO on the Hong Kong Stock Exchange [3][4]. Group 1: Business Overview - Founded in 2014, Qingsong Health Group operates as a one-stop digital health and insurance service platform, with two main business pillars: "Digital Comprehensive Health Services" and "Digital Comprehensive Insurance Services" [3]. - According to a report by Sullivan, Qingsong Health Group ranks 10th in China's digital comprehensive health services and health insurance market based on projected 2024 revenue, and 7th in the digital health services market [3]. - As of June 30, 2025, the platform has 168 million registered users and approximately 59.7 million followers across WeChat, mini-programs, and corporate WeChat accounts [3]. Group 2: User Demographics and Growth Potential - As of June 30, 2025, about 60.4% of users are aged between 20 and 45 years, indicating a younger user base that is likely to increase health solution spending as they experience life events such as marriage and childbirth [4]. - This demographic trend provides significant upselling and cross-selling opportunities for Qingsong Health Group to maximize customer lifetime value [4]. - The younger users also invite family members to purchase health and insurance services, further enhancing growth potential [4]. Group 3: Technological Advancements - AI technology is a crucial growth engine for Qingsong Health Group, with 43.3% of its employees dedicated to IT research and development [4]. - The company has registered 58 invention patents and 39 software copyrights related to its technological capabilities as of June 30, 2025 [4]. - The Galaxy AI marketing platform has generated nearly 12.9 million business leads through personalized marketing activities [5]. Group 4: Financial Performance - Qingsong Health Group's revenue from 2022 to 2024 is projected to be 394 million, 490 million, and 945 million yuan, respectively, with a compound annual growth rate of 54.9% [5]. - In the first half of this year, the company's revenue increased by 84.7% year-on-year to 656 million yuan, while the adjusted net profit for the same period was 51.18 million yuan, reflecting an 11.3% year-on-year growth [5]. Group 5: IPO Fund Utilization - The net proceeds from the IPO will primarily be used to enhance brand awareness, increase user engagement, strengthen partnerships, conduct medical and real-world research, improve AI and big data capabilities, expand into more regions and overseas markets, and for general corporate purposes [6].